Episode 3: Improving Access, Affordability, and Adherence in Pharma with Conversational AI

"What pharma is really trying to help with right now, while many Americans are struggling, is to communicate to them and educate them of the different opportunities they have to get financial assistance." -Whitaker

EPISODE RECAP

During this episode, host Nate Treloar discusses AI-powered solutions in pharma with Elise Whitaker, VP Customer Success & Practice Lead, Pharmaceuticals & Life Sciences at Orbita. The COVID-19 pandemic has compromised the access that millions have to healthcare and essential treatments. From asthma diagnoses to cancer, Elise and Nate explore the complexities around access, affordability, and adherence. What can pharma companies do to meet patients and HCPs where they are? How can conversational AI improve access? Join the conversation and learn more about financial assistance programs and new modules including adverse event detection features that empower pharma to embrace new technology.

Listening to this podcast episode, you'll gain insights on:

• The disparities in how people manage and maintain their healthcare
• The role of affordability in barring patients from acquiring healthcare, for example, out-of-pocket costs for cancer treatment alone can reach upwards of $30,000 per year
• How pharmaceutical companies can inform patients about financial assistance programs
• How to address the inequities of access, adherence, and affordability today

The implementation of conversational AI in pharmaceutical companies' patient and HCP contact points can deliver a wide-range of support. Episode 3 of the podcast explores how an intelligent virtual assistant can guide patients through their care treatment plans - how to use whatever equipment is required, what medication to take, and reminders of when to take care. Additionally, 24/7 on-demand chat and voice solutions are also powerful educators and can deliver financial resources, appointment scheduling support, and Q&A tools.